| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte Corporation | 17.47% | 30,743,663 | $2,607,370,059 | 388 | 0.00126% | $84.81 | 13F |
| MDGL | Madrigal Pharmaceuticals, Inc. | 6.58% | 2,141,701 | $982,312,581 | 165,683 | 8.38% | $458.66 | 13F |
| KYMR | Kymera Therapeutics, Inc. | 4.59% | 7,955,916 | $684,208,776 | 1,304,487 | 19.61% | Form 4 | |
| RVMD | Revolution Medicines, Inc. | 2.96% | 9,455,357 | $441,565,172 | 90,385 | 0.97% | $46.7 | 13F |
| KOD | Kodiak Sciences Inc. | 2.89% | 18,358,772 | $422,251,756 | 1,048,282 | 6.06% | Form 4 | |
| CELC | Celcuity Inc. | 2.62% | 7,915,792 | $391,040,125 | 2,465,347 | 45.23% | $49.4 | 13F |
| ALKS | Alkermes plc | 1.63% | 8,091,351 | $242,740,530 | 1,680,748 | 26.22% | $30 | 13F |
| IMTX | Immatics N.V. | 0.69% | 12,094,094 | $103,041,681 | 1,925,193 | 18.93% | $8.52 | 13F |
| IDYA | IDEAYA Biosciences, Inc. | 0.60% | 3,275,444 | $89,124,831 | 1,156,716 | 54.59% | $27.21 | 13F |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 0.39% | 1,670,762 | $57,624,581 | 731,588 | 77.9% | $34.49 | 13F |
| NTLA | Intellia Therapeutics, Inc. | 0.32% | 2,746,674 | $47,435,060 | 71,000 | 2.65% | $17.27 | 13F |
| RAPP | Rapport Therapeutics, Inc. | 0.31% | 1,547,090 | $45,948,573 | 997,000 | 181.24% | $29.7 | 13F |
| SYRE | Spyre Therapeutics, Inc. | 0.11% | 1,000,000 | $16,760,000 | 373,297 | 59.57% | $16.76 | 13F |
| CTMX | CytomX Therapeutics, Inc. | 0.09% | 4,250,826 | $13,560,135 | 766,600 | 22% | $3.19 | 13F |
| XNCR | Xencor, Inc. | 0.09% | 1,102,106 | $12,927,703 | 431,675 | 64.39% | $11.73 | 13F |
| VTVT | vTv Therapeutics, Inc. | 0.02% | 148,314 | $3,463,132 | 51,000 | 52.41% | $23.35 | 13F |